VERICEL CORPORATION Deferred Rent Credit
VERICEL CORPORATION (VCEL) had Deferred Rent Credit of $1.90 million as of 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCredit · last filed 2019-08-06
- 2019-06-30: Deferred Rent Credit $1.90M.
- 2019-03-31: Deferred Rent Credit $1.90M.
- 2018-12-31: Deferred Rent Credit $1.90M.
- 2018-09-30: Deferred Rent Credit $1.90M.
| Period end | Deferred Rent Credit |
|---|---|
| 2019-06-30 | $1.90M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.90M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.90M 10-K · filed 2019-02-26 |
| 2018-09-30 | $1.90M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.90M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $1.70M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.70M 10-K · filed 2018-03-05 |
| 2017-09-30 | $1.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $900.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $900.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $900.00K 10-K · filed 2017-03-13 |
| 2016-09-30 | $900.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $900.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |